News Focus
News Focus
icon url

learningcurve2020

11/25/23 12:15 PM

#650518 RE: flipper44 #650516

Where's the company PR? ...Where's all the damage control by a management that appears to know various pros are gunning for them? Let me guess, Powers was away for the holiday. Got it.
icon url

Arby2000

11/25/23 3:19 PM

#650556 RE: flipper44 #650516

It is now established that NWBIO is close (OK, several weeks) to submitting an application to the MHRA. There will then be a longish period while MHRA goes through its process of reviewing, evaluating, and deciding on the MA for DCVAX-L The regulators at MHRA or anywhere else are not going to use the paper for their decision. However, the shorts, adversarial MMs, and their fudster troops need a publicly posted cover for their attacks and stock during this period. Just like the AF article that was used by Citadel in one of its filings to justify its trading attacks, I believe this article, co-authored and posted as an Editor's Choice by an Associate Editor of SNO, is intended to provide that cover during this period.
Bullish
Bullish
icon url

attilathehunt

11/26/23 12:44 PM

#650728 RE: flipper44 #650516

keep in mind the following..Wonder how much KG spent to commissioned said article?????


Dr. E. Antonio Chiocca is the Harvey Cushing Professor of Neurosurgery at Harvard Medical School


Ken Griffin, a billionaire hedge fund manager and philanthropist, has donated a total of over $550 million to Harvard University throughout his lifetime. His largest single donation was $300 million in 2023, which was given to the Faculty of Arts and Sciences (FAS) to support the School's mission and to advance cutting-edge research and expand access and excellence in education for students and scholars regardless of economic circumstances. In recognition of Griffin's commitment to Harvard's mission over the years, the Graduate School of Arts and Sciences was renamed the Harvard Kenneth C. Griffin Graduate School of Arts and Sciences in his honor.